• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

作者信息

Levine Glenn N, Bates Eric R, Bittl John A, Brindis Ralph G, Fihn Stephan D, Fleisher Lee A, Granger Christopher B, Lange Richard A, Mack Michael J, Mauri Laura, Mehran Roxana, Mukherjee Debabrata, Newby L Kristin, O'Gara Patrick T, Sabatine Marc S, Smith Peter K, Smith Sidney C, Halperin Jonathan L, Levine Glenn N, Al-Khatib Sana M, Birtcher Kim K, Bozkurt Biykem, Brindis Ralph G, Cigarroa Joaquin E, Curtis Lesley H, Fleisher Lee A, Gentile Federico, Gidding Samuel, Hlatky Mark A, Ikonomidis John S, Joglar José A, Pressler Susan J, Wijeysundera Duminda N

出版信息

J Thorac Cardiovasc Surg. 2016 Nov;152(5):1243-1275. doi: 10.1016/j.jtcvs.2016.07.044.

DOI:10.1016/j.jtcvs.2016.07.044
PMID:27751237
Abstract
摘要

相似文献

1
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2016美国心脏病学会/美国心脏协会关于冠心病患者双联抗血小板治疗疗程的重点更新指南：美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Thorac Cardiovasc Surg. 2016 Nov;152(5):1243-1275. doi: 10.1016/j.jtcvs.2016.07.044.
2
Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.双联抗血小板治疗的疗程：针对2016年美国心脏病学会/美国心脏协会关于冠心病患者双联抗血小板治疗疗程重点更新指南的系统评价：美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2016 Sep 6;134(10):e156-78. doi: 10.1161/CIR.0000000000000405. Epub 2016 Mar 29.
3
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.2016年美国心脏病学会/美国心脏协会关于冠状动脉疾病患者双联抗血小板治疗时长的聚焦更新：美国心脏病学会/美国心脏协会临床实践指南工作组报告：2011年美国心脏病学会基金会/美国心脏协会/心血管造影和介入学会经皮冠状动脉介入治疗指南、2011年美国心脏病学会基金会/美国心脏协会冠状动脉旁路移植手术指南、2012年美国心脏病学会/美国心脏协会/美国内科医师学会/美国胸外科医师协会/美国预防心脏病学会/心血管造影和介入学会/美国胸外科医师学会稳定型缺血性心脏病患者诊断和管理指南、2013年美国心脏病学会基金会/美国心脏协会ST段抬高型心肌梗死管理指南、2014年美国心脏协会/美国心脏病学会非ST段抬高型急性冠状动脉综合征患者管理指南以及2014年美国心脏病学会/美国心脏协会非心脏手术患者围手术期心血管评估和管理指南的更新
Circulation. 2016 Sep 6;134(10):e123-55. doi: 10.1161/CIR.0000000000000404. Epub 2016 Mar 29.
4
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2016美国心脏病学会/美国心脏协会关于冠状动脉疾病患者双联抗血小板治疗持续时间的指南聚焦更新：美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2016 Sep 6;68(10):1082-115. doi: 10.1016/j.jacc.2016.03.513. Epub 2016 Mar 29.
5
Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.双联抗血小板治疗时间：2016 年 ACC/AHA 指南双联抗血小板治疗时间的聚焦更新：冠心病患者双联抗血小板治疗时间的临床实践指南——美国心脏病学会/美国心脏协会工作组报告。
J Am Coll Cardiol. 2016 Sep 6;68(10):1116-39. doi: 10.1016/j.jacc.2016.03.512. Epub 2016 Mar 29.
6
ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison.ACC/AHA 与 ESC 双重抗血小板治疗指南：JACC 指南比较。
J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2915-2931. doi: 10.1016/j.jacc.2018.09.057.
7
2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.2019年美国心脏协会/美国心脏病学会/心律学会对2014年美国心脏协会/美国心脏病学会/心律学会心房颤动患者管理指南的重点更新：美国心脏病学会/美国心脏协会临床实践指南工作组和心律学会的报告
Heart Rhythm. 2019 Aug;16(8):e66-e93. doi: 10.1016/j.hrthm.2019.01.024. Epub 2019 Jan 28.
8
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons.2019年美国心脏协会/美国心脏病学会/心律学会对2014年美国心脏协会/美国心脏病学会/心律学会心房颤动患者管理指南的聚焦更新：美国心脏病学会/美国心脏协会临床实践指南工作组和心律学会与胸外科医师协会合作报告
Circulation. 2019 Jul 9;140(2):e125-e151. doi: 10.1161/CIR.0000000000000665. Epub 2019 Jan 28.
9
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).2017年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的冠状动脉疾病双联抗血小板治疗重点更新：欧洲心脏病学会（ESC）和欧洲心胸外科学会（EACTS）冠状动脉疾病双联抗血小板治疗特别工作组。
Eur Heart J. 2018 Jan 14;39(3):213-260. doi: 10.1093/eurheartj/ehx419.
10
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2023 年 AHA/ACC/ACCP/ASPC/NLA/PCNA 慢性冠状动脉疾病患者管理指南：美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
Circulation. 2023 Aug 29;148(9):e9-e119. doi: 10.1161/CIR.0000000000001168. Epub 2023 Jul 20.

引用本文的文献

1
External Validation of the PRECISE-DAPT Cancer Score in Patients With Acute Myocardial Infarction.急性心肌梗死患者中PRECISE-DAPT癌症评分的外部验证
Catheter Cardiovasc Interv. 2025 Sep;106(3):1912-1919. doi: 10.1002/ccd.70040. Epub 2025 Jul 22.
2
Assessing the efficacy and safety of low dose clopidogrel in Chinese ACS patients undergoing PCI: A retrospective study.评估低剂量氯吡格雷对接受经皮冠状动脉介入治疗的中国急性冠状动脉综合征患者的疗效和安全性：一项回顾性研究。
Medicine (Baltimore). 2025 May 30;104(22):e42551. doi: 10.1097/MD.0000000000042551.
3
Elderly patients are hyperresponsive to potent P2Y12 inhibitors.
老年患者对强效P2Y12抑制剂反应过度。
Res Pract Thromb Haemost. 2025 Feb 20;9(2):102704. doi: 10.1016/j.rpth.2025.102704. eCollection 2025 Feb.
4
Association of Per- and Polyfluoroalkyl Substance Exposure with Coronary Stenosis and Prognosis in Acute Coronary Syndrome.全氟和多氟烷基物质暴露与急性冠状动脉综合征中冠状动脉狭窄及预后的关联
Environ Health (Wash). 2024 Dec 3;3(3):291-307. doi: 10.1021/envhealth.4c00166. eCollection 2025 Mar 21.
5
Discovery of ancestry-specific variants associated with clopidogrel response among Caribbean Hispanics.在加勒比西班牙裔人群中发现与氯吡格雷反应相关的特定血统变异。
NPJ Genom Med. 2025 Mar 7;10(1):20. doi: 10.1038/s41525-025-00479-3.
6
Heart Rate Variability and Coronary Artery Bypass Grafting: A Systematic Review.心率变异性与冠状动脉旁路移植术：一项系统评价
Rev Cardiovasc Med. 2024 Jan 22;25(1):36. doi: 10.31083/j.rcm2501036. eCollection 2024 Jan.
7
A practical guide to the management of immune thrombocytopenia co-existing with acute coronary syndrome.免疫性血小板减少症合并急性冠状动脉综合征管理实用指南
Front Med (Lausanne). 2024 Apr 11;11:1348941. doi: 10.3389/fmed.2024.1348941. eCollection 2024.
8
Global antiplatelet sales trend: A focus on P2Y12 inhibitors from 2008 to 2018.全球抗血小板药物销售趋势：聚焦2008年至2018年的P2Y12抑制剂
Am Heart J Plus. 2021 Jun 16;4:100020. doi: 10.1016/j.ahjo.2021.100020. eCollection 2021 Apr.
9
Effect of cytochrome P450 2C19 (CYP2C19) gene polymorphism and clopidogrel reactivity on long term prognosis of patients with coronary heart disease after PCI.细胞色素P450 2C19（CYP2C19）基因多态性及氯吡格雷反应性对冠心病患者PCI术后长期预后的影响
J Geriatr Cardiol. 2024 Jan 28;21(1):90-103. doi: 10.26599/1671-5411.2024.01.004.
10
Impact of the reporting source on Platelet Inhibition and Treatment Outcomes (PLATO) trial deaths.报告来源对血小板抑制和治疗结果（PLATO）试验死亡情况的影响。
Discoveries (Craiova). 2023 Sep 25;11(3):e174. doi: 10.15190/d.2023.13. eCollection 2023 Jul-Sep.